A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines. [electronic resource]
Producer: 20160922Description: 385-98 p. digitalISSN:- 1791-2423
- Apoptosis -- drug effects
- Breast Neoplasms -- drug therapy
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cell Movement -- drug effects
- Curcumin -- administration & dosage
- Drug Synergism
- Female
- Human Umbilical Vein Endothelial Cells
- Humans
- Neoplasm Invasiveness -- genetics
- Raloxifene Hydrochloride -- administration & dosage
- Receptors, Estrogen -- genetics
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.